Publications

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

 71
Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

Tags:

Previous Article

Immunotherapy for difficult-to-treat brain tumors with gut microbiota

Next Article

Role of plasmin in metastatic tumors

Related Posts

Endometriosis

Endometriosis

 285

A prefrontal thalamocortical readout for conflict- related executive dysfunction in schizophrenia

A prefrontal thalamocortical readout for conflict- rela...

 100

Rho-dependent transcriptional switches regulate the bacterial response to cold shock

Rho-dependent transcriptional switches regulate the bac...

 102